NL-OMON55867招募中3 期
Chemotherapy in KRAS mutated chemotherapy naive non-small cell lung cancer patients: a phase III study comparing cisplatin-pemetrexed with carboplatin-paclitaxel-bevacizumab: NVALT 22 - NVALT 22
Stichting NVALT studies0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Histologically or cytologically confirmed NSCLC (Stage IIIB or IV)
- •Documented KRAS mutation
- •Chemotherapy-naive NSCLC patients
- •ECOG PS 0-2
- •Age 18 years or older
- •Adequate bone marrow, hepatic and renal function
排除标准
- •Pregnant or lactating women
- •Active cardiovascular disease
- •History of hemoptysis greater or equal to grade 2
- •Evidence of tumor invading major blood vessels on imaging
研究者
相似试验
进行中（未招募）
1 期
Chemotherapy in non-small cell lung cancer patients with a KRAS mutation in the tumor. Comparing two schedules: cisplatin-pemetrexed with carboplatin-paclitaxel-bevacizumab: NVALT 22Advanced non-small cell lung cancerMedDRA version: 21.1Level: PTClassification code 10029515Term: Non-small cell lung cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-003121-34-NLStichting NVALT studies240
尚未招募
2 期
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIAesophageal cancerNL-OMON49762Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
不适用
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with oligometastatic diseaseNL-OMON23939Erasmus MC20
进行中（未招募）
1 期
Chemotherapy followed by chemoradiotherapy for metastatic esophageal cancerPatients (18 – 75 years) who are diagnosed with adenocarcinoma of the oesophagus or GOJ with a resectable primary tumour and de-novo synchronous oligometastatic disease.EUCTR2020-003605-55-NLErasmus MC - University Medical Centre20
已完成
不适用
KHAN1 - A Trial of Chemotherapy With Radiotherapy in the Treatment of Advanced Squamous Carcinoma of the Head and NeckHead and neck cancerCancerISRCTN93127929Cancer Research UK (CRUK) (UK)